SYDNEY, Australia, Nov. 15 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced the appointment of Dr John Villiger as a new board director.
Dr Villiger brings strong international pharmaceutical development experience to Pharmaxis, having created a successful NASDAQ-listed pharmaceutical company and holding senior global roles at Roche.
“We are delighted to have John join our board,” said Pharmaxis CEO Alan Robertson. “His expertise in bringing products to market will be a valuable complement to the existing Board members’ skills.”
Dr Villiger co-founded The Medicines Company in 1996, and was Senior Vice President of Development until February this year. This business is NASDAQ listed with market capitalisation of US$1.25 billion, 300 employees and around US$220 million in projected 2006 sales.
Previously, Dr Villiger held various senior positions in product development at Roche from 1986 to 1996 in New Zealand and Switzerland, including International Project Director and Head of Global Project Management. He oversaw the development of Roche’s pharmaceutical portfolio, managing over 50 development programs and teams in Switzerland, the UK, USA and Japan. John has a PhD from the University of Otago and is widely published.
“Pharmaxis is at the cusp of bringing significant advances in treating respiratory diseases to patients worldwide,” said Dr Villiger. “I look forward to supporting this with the knowledge, experience and contacts I’ve developed over the past 20 years in developing new medicines for global markets.”
Details on other Pharmaxis board directors can be found at http://www.pharmaxis.com.au/investors/annual-reports/annual-reports_home.cfm
Released through: United States: Brandon Lewis, Trout Group Tel: +1-212-477-9007 Email: blewis@troutgroup.com Australia: Virginia Nicholls Tel: +61-417-610-824 Email: virginia.nicholls@pharmaxis.com.au CONTACT: Alan Robertson -- Chief Executive Officer Tel: +61-2-9454-7200
Pharmaxis Ltd
CONTACT: Alan Robertson of Pharmaxis, +61-2-9454-7200,arobertson@pharmaxis.com.au; Brandon Lewis in US of Trout Group forPharmaxis, +1-212-477-9007, blewis@troutgroup.com; Virginia Nicholls inAustralia for Pharmaxis, +61-417-610-824
Web site: http://www.pharmaxis.com.au/
